Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl

Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.

Other Latest News
- US Tariffs: Global Brokerage Firm Citi Sees Minimal Impact On Indian Pharma Firms April 1, 2025 11:25 am MENAFN (MENAFN- IANS) Mumbai, April 1 (IANS) Global brokerage firm Citi said on Tuesday there is a low likelihood of the US imposing tariffs on Indian pharmaceuticals, despite ongoing discussions around the issue.The brokerage firm analysed the potential effects …
- Pharma Pulse 4/1/25: Restructuring Medical Device Supply Chains, Role of Pharmacists in COVID-19 Care and Prevention & more April 1, 2025 11:22 am Pharmaceutical Commerce Restructuring Medical Device Supply Chains to Withstand Global Emergencies Marcel Botha, CEO of 10XBeta, identifies actionable steps that can be taken to restructure medical device supply networks to better withstand future global emergencies. Expert Q…
- Exclusive-Pharma industry lobbies Trump for phased tariffs, sources say April 1, 2025 10:26 am Yahoo Finance By Maggie Fick and Michael Erman LONDON/NEW YORK (Reuters) -Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time to shift …
- Emcure Pharma arm Gennova advances development of Nipah virus vaccine April 1, 2025 10:05 am Medical Dialogues Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking self-amplifying mRNA (saRNA) vaccine against the deadly Nipah virus. This critical initiative is supported by an expanded …
- LFA First Division League Is Back in Action April 1, 2025 9:03 am Liberian Observer The 2024/25 LFA League season enters its final four game weeks, FC Fassell stands on the brink of claiming their first title. Heaven Eleven trails the leading team by nine points, while the battle for a spot in the Orange Cup Semi-Final remains fierce. …
- Eisai To Divest Rights For Pariet In China To Peak Pharma April 1, 2025 8:13 am MENAFN (MENAFN- JCN NewsWire) Eisai to Divest Rights for Pariet in China to Peak Pharma TOKYO, Apr 1, 2025 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has entered into an agreement to divest the rights for proton pump inhibitor Pariet® (generic …
- Intas Pharmaceuticals President – Global HR Ajay Bhatt Retires April 1, 2025 8:10 am SightsIn Plus Ajay Bhatt, a distinguished leader in healthcare human resources, has retired from his role as President-Global HR at Intas Pharmaceuticals. With an illustrious career spanning 38 years, Ajay has left an indelible mark on the pharmaceutical industry, …
- Global cost of Trump trade war ‘could reach $1.4tn’; tariff fears hurt UK factories April 1, 2025 7:28 am The Guardian Global cost of 2025 tariff war could reach $1.4tn, report findsA full-blown trade war between the US and its trading partners could cost $1.4tn, a new report shows. Economists at Aston Business School have modelled a range of potential scenarios, including …
- Nxera Pharma Announces Appointments to its Executive Leadership Team April 1, 2025 7:00 am EIN Presswire Mr. Kiyoshi Kaneko appointed as Chief Commercial Officer, and Ms. Mariko Nakafuji promoted to Chief Legal Officer Tokyo, Japan and Cambridge, UK, 1 April 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces two new …
- Global cost of Trump trade war ‘could reach $1.4tn’; tariff fears hurt UK factories – business live April 1, 2025 6:59 am The Guardian Global cost of 2025 tariff war could reach $1.4tn, report findsA full-blown trade war between the US and its trading partners could cost $1.4tn, a new report shows. Economists at Aston Business School have modelled a range of potential scenarios, including …
- What's Next for Pharma Supply Chain? Explore at PHARMAP 2025 April 1, 2025 6:08 am Life Sciences Review Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic …
- Indian pharma prioritizes skilled workforce proficient in techy & regulatory compliance to meet evolving market needs April 1, 2025 5:30 am Pharmabiz.com Indian pharmaceutical sector demands a highly skilled workforce proficient in technology, data science, and regulatory compliance. This is because as the global pharma and life sciences landscape evolves rapidly, hiring trends and talent retention …
- Which Indian pharma stocks will outperform bank deposits? April 1, 2025 4:21 am Mint No matter how slow the current profit growth is, these companies spend on research and development (R&D) for future growth. No matter how stiff the competition is, their patents protect them. No matter how weak the economy is, these companies continue …
- Pharma Live Expo to be held in Mumbai from April 17 to 19 April 1, 2025 3:54 am Pharmabiz.com The third edition of Pharma Live Expo & Summit, a premier event for the global pharmaceutical, healthcare, and MedTech sectors, will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Organized by ICEXPO Consults in …
- DMart, TCPL, Divis Labs, Deepak Fertilizers: 4 stock picks from SMC Global for decent gains April 1, 2025 3:08 am Business Today Amid the volatility in the Indian stock markets, domestic brokerage firm SMC Global Securities has suggested four stocks- Deepak Fertilisers and Petrochemicals, Divis Laboratories, Avenue Supermarts (DMart) and Tata Consumer Products (TCPL) – to bet amid …
- Stock Market Live Updates 1 April 2025: Sensex, Nifty brace for FY26 volatility amid global headwinds, trump tariff concerns April 1, 2025 2:22 am The Hindu Business Line NHPC: Company announced the successful completion of the trial run for Unit1 (200 MW) of the Parbati-II HE Project (800 MW) in Himachal Pradesh (Positive) Gail: Company to Get Pipeline Tariff Boost, Margins to Rise by Rupees 3,400 Cr – ET. (Positive) …
- Sun Pharma Advanced Research files IND for SBO-154 for advanced solid tumors March 31, 2025 11:53 pm BioWorld Immuno-oncology Sun Pharma Advanced Research Co. Ltd. has filed an IND application with the FDA for SBO-154 for the treatment of solid tumors. A global phase I study is planned in advanced solid tumors. BioWorld Science Regulatory Cancer Antibody-drug …
- Industry Outlook 2025: Business Viability and Global Collaboration March 31, 2025 10:40 pm Pharmaceutical Technology Being realistic about the viability of business, finances, technology, and the success of drug products, as well as getting back to the basics, are trends from 2024 that have impacted the bio/pharmaceutical industry, according to Alexander Seyf, CEO …
- Big Pharma Faces Tariff Fears—Will K-Beauty Gain an Edge? March 31, 2025 8:04 pm The Santa Clarita Valley Signal – California Pharmaceutical Giants Brace for Tariff Impact The U.S. and European Union are locked in a trade dispute that could result in heavy tariffs on European-made medical goods. Major pharmaceutical companies like Novo Nordisk and Merck fear that increased costs …
- LSL Pharma Group appoints Louis Laflamme to the board of directors March 31, 2025 6:47 pm Canadian Manufacturing BOUCHERVILLE — LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, announces the appointment of Louis Laflamme as a member of the board of directors. “We are delighted to see Louis, a renowned leader in the health industry, join our board …
- DHL to buy US pharma logistics specialist CryoPDP for $195M March 31, 2025 5:00 pm FreightWaves DHL Group has agreed to acquire Nashville, Tennessee-based CryoPDP, a specialty courier that provides logistics services for clinical trials, biopharma, and cell and gene therapies, for $195 million, the integrated logistics carrier announced Monday. The …
- Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer’s Dementia March 31, 2025 3:07 pm The Laotian Times TOKYO, March 31, 2025 /PRNewswire/ — Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a …
- Futures, Global Markets Tumble On Tariff Tiff, Gold Soars To New Record High March 31, 2025 2:50 pm Zero Hedge US equity futures and global markets tumbled on the last day of the worst quarter for US stocks in 23 years as the April 2 "liberation day" comes into sharp view. As of 8:00a, S&P futures are down 1.1% after Trump dented hopes he would limit …
- Germany’s DHL to acquire US pharma logistics firm Cryopdp March 31, 2025 2:01 pm KFGO – North Dakota DUSSELDORF, Germany (Reuters) -DHL said on Monday it will acquire U.S. pharmaceutical logistics firm Cryopdp as part of the German company’s efforts to grow its operations in the pharma sector, confirming an earlier report by Reuters. DHL did not disclose …
- China's medical reform fasttracks innovation: U.S. pharma giant March 31, 2025 1:37 pm Xinhua News Agency BEIJING, March 31 (Xinhua) — China's reform efforts to promote research and development on medical innovation and shorten the review and approval time for the launch of related drugs have provided innovation-driven pharmaceutical firms with greater …